首页> 美国卫生研究院文献>Proceedings of the National Academy of Sciences of the United States of America >PNAS Plus: IκB kinase-induced interaction of TPL-2 kinase with 14-3-3 is essential for Toll-like receptor activation of ERK-1 and -2 MAP kinases
【2h】

PNAS Plus: IκB kinase-induced interaction of TPL-2 kinase with 14-3-3 is essential for Toll-like receptor activation of ERK-1 and -2 MAP kinases

机译:PNAS Plus:IκB激酶诱导的TPL-2激酶与14-3-3的相互作用对于Toll样受体激活ERK-1和-2 MAP激酶至关重要

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The MEK-1/2 kinase TPL-2 is critical for Toll-like receptor activation of the ERK-1/2 MAP kinase pathway during inflammatory responses, but it can transform cells following C-terminal truncation. IκB kinase (IKK) complex phosphorylation of the TPL-2 C terminus regulates full-length TPL-2 activation of ERK-1/2 by a mechanism that has remained obscure. Here, we show that TPL-2 Ser-400 phosphorylation by IKK and TPL-2 Ser-443 autophosphorylation cooperated to trigger TPL-2 association with 14-3-3. Recruitment of 14-3-3 to the phosphorylated C terminus stimulated TPL-2 MEK-1 kinase activity, which was essential for TPL-2 activation of ERK-1/2. The binding of 14-3-3 to TPL-2 was also indispensible for lipopolysaccharide-induced production of tumor necrosis factor by macrophages, which is regulated by TPL-2 independently of ERK-1/2 activation. Our data identify a key step in the activation of TPL-2 signaling and provide a mechanistic insight into how C-terminal deletion triggers the oncogenic potential of TPL-2 by rendering its kinase activity independent of 14-3-3 binding.
机译:MEK-1 / 2激酶TPL-2对于炎症反应期间ERK-1 / 2 MAP激酶途径的Toll样受体活化至关重要,但它可以在C端截短后转化细胞。 TPL-2 C末端的IκB激酶(IKK)复合物磷酸化通过一直不清楚的机制调节ERK-1 / 2的全长TPL-2活化。在这里,我们显示IKK和TPL-2 Ser-443自磷酸化作用使TPL-2 Ser-400磷酸化协同触发TPL-2与14-3-3的缔合。向磷酸化的C末端募集14-3-3会刺激TPL-2 MEK-1激酶活性,这对于TPL-2激活ERK-1 / 2至关重要。 14-3-3与TPL-2的结合对于脂多糖诱导的巨噬细胞肿瘤坏死因子的产生也是必不可少的,巨噬细胞受TPL-2的调节而不受ERK-1 / 2活化的影响。我们的数据确定了激活TPL-2信号的关键步骤,并提供了有关C末端缺失如何通过使其激酶活性独立于14-3-3结合而触发TPL-2致癌潜力的机制的见解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号